AVDL Avadel Pharmaceuticals
- 10.610
- +0.380+3.71%
- 10.610
- 0.0000.00%
Avadel Pharmaceuticals News
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Palczuk Linda
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MCHUGH THOMAS S
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MCHUGH THOMAS S
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Divis Gregory J
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Glass Geoffrey Michael
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Palczuk Linda
Avadel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(13.8%),Janus Henderson Biotech Innovation Master Fund Ltd(5.0%)
Avadel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(0%),Roderick Wong, M.D.(0%)
Avadel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Polar Capital Holdings Plc(4.99%),Polar Capital LLP(4.99%)
Avadel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cowen and Company, LLC(0%),Cowen Financial Products LLC(0%)
Avadel Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.5%)
Avadel Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.5%)
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Palczuk Linda
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Glass Geoffrey Michael
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Palczuk Linda
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Thornton Peter J.
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Amin Naseem
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ende Eric J
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director McCamish Mark Anthony
Avadel Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Glass Geoffrey Michael
No Data